FEIM vs. CTKB, SENS, LAB, EYPT, ALNT, QTRX, QSI, AEHR, MASS, and KEQU
Should you be buying Frequency Electronics stock or one of its competitors? The main competitors of Frequency Electronics include Cytek Biosciences (CTKB), Senseonics (SENS), Standard BioTools (LAB), EyePoint Pharmaceuticals (EYPT), Allient (ALNT), Quanterix (QTRX), Quantum-Si (QSI), Aehr Test Systems (AEHR), 908 Devices (MASS), and Kewaunee Scientific (KEQU). These companies are all part of the "measuring and control equipment" industry.
Frequency Electronics vs.
Frequency Electronics (NASDAQ:FEIM) and Cytek Biosciences (NASDAQ:CTKB) are both small-cap computer and technology companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, earnings, community ranking, valuation, profitability, dividends, institutional ownership, analyst recommendations and media sentiment.
Frequency Electronics received 66 more outperform votes than Cytek Biosciences when rated by MarketBeat users. Likewise, 60.69% of users gave Frequency Electronics an outperform vote while only 45.83% of users gave Cytek Biosciences an outperform vote.
Frequency Electronics has higher earnings, but lower revenue than Cytek Biosciences. Cytek Biosciences is trading at a lower price-to-earnings ratio than Frequency Electronics, indicating that it is currently the more affordable of the two stocks.
Frequency Electronics has a net margin of 13.02% compared to Cytek Biosciences' net margin of -5.05%. Frequency Electronics' return on equity of 21.49% beat Cytek Biosciences' return on equity.
In the previous week, Frequency Electronics had 1 more articles in the media than Cytek Biosciences. MarketBeat recorded 4 mentions for Frequency Electronics and 3 mentions for Cytek Biosciences. Frequency Electronics' average media sentiment score of 1.21 beat Cytek Biosciences' score of -0.10 indicating that Frequency Electronics is being referred to more favorably in the media.
58.6% of Frequency Electronics shares are held by institutional investors. Comparatively, 69.5% of Cytek Biosciences shares are held by institutional investors. 26.1% of Frequency Electronics shares are held by insiders. Comparatively, 9.6% of Cytek Biosciences shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Frequency Electronics has a beta of 0.41, suggesting that its share price is 59% less volatile than the S&P 500. Comparatively, Cytek Biosciences has a beta of 1.41, suggesting that its share price is 41% more volatile than the S&P 500.
Cytek Biosciences has a consensus target price of $6.42, suggesting a potential upside of 79.14%. Given Cytek Biosciences' stronger consensus rating and higher probable upside, analysts plainly believe Cytek Biosciences is more favorable than Frequency Electronics.
Summary
Frequency Electronics beats Cytek Biosciences on 11 of the 18 factors compared between the two stocks.
Get Frequency Electronics News Delivered to You Automatically
Sign up to receive the latest news and ratings for FEIM and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Frequency Electronics Competitors List
Related Companies and Tools
This page (NASDAQ:FEIM) was last updated on 4/4/2025 by MarketBeat.com Staff